1.Date of the shareholders' meeting resolution:2024/05/24

2.Name and title of the managerial officer with permission to engage in competitive conduct:
(1)Representative of TTY Biopharm Company Limited:Carl Hsiao;Director
(2)Representative of TTY Biopharm Company Limited:Kang-Chi Chou;Director
(3)Yuen-Liang Lai;Independent Director

3.Items of competitive conduct in which the officer is permitted to engage:Similiar scope of business of director of management

4.Period of permission to engage in the competitive conduct:The period of being director of the Company.

5.Circumstances of the resolution (please describe the results of voting in accordance with Article 209 of the Company Act):
(1)23,535,438 in total voting rights were represented at the time of voting;
(2)23,450,891 voting right presented for, 99.64% of total voting rights;
(3)46,682 voting right presented against, 0.19% of total voting rights;
(4)0 invalid votes, 0% of total voting rights;
(5)37,865 voting right presented abstention and not voting, 0.16% of total voting rights;
(6)this proposal was approved as proposed as affirmative rights higher than statutory ones.

6.If the permitted competitive conduct belongs to the operator of a mainland China enterprise, the name and title of the directors (if it is not the operator of a mainland China enterprise, please enter “N/A” below):NA.

7.Company name of the mainland China enterprise and the officer’s position in the enterprise:NA.

8.Address of the mainland China enterprise:NA.

9.Operations of the mainland China enterprise:NA.

10.Impact on the company’s finance and business:None.

11.If the directors have invested in the mainland China enterprise, the monetary amount of the investment and their shareholding ratio:NA.

12.Any other matters that need to be specified:None.